Better mattresses improve care, cut hospital costs

 

Toronto, Canada (August 17, 2011) — Hospitals could reduce health care costs arising from pressure ulcers, commonly known as bedsores, by investing in pressure-reduction mattresses for elderly patients in emergency departments, according to new research from the University of Toronto.

 

In emergency departments (EDs), elderly patients are at high risk for pressure ulcers in part because they spend hours lying on hard surfaces. The researchers found that while the average cost of upgrading from standard to pressure-redistribution mattresses would be 30 cents per patient, the corresponding reduction in pressure-ulcer incidence would produce savings of $32 per patient.

 

"Most pressure ulcers are preventable, which is why the U.S. Centers for Medicare and Medicaid Services considers them a ‘never event’ and won’t reimburse their treatment," said Ba’ Pham, lead author on the study and a senior research associate with the Toronto Health Economics and Technology Assessment (THETA) Collaborative. "Upgrading mattress quality would save money and improve quality of life for elderly patients in emergency departments," said Pham, who is also completing his training at U of T’s Department of Health Policy, Management and Evaluation.

 

In their study, published in Annals of Emergency Medicine, the researchers performed a cost-effectiveness analysis based on data drawn primarily from Ontario. They compared the projected incidence of pressure ulcers based on current practices in EDs with projected incidence after introduction of better mattresses and found that early prevention was likely to be cost-effective 81% of the time.

 

As part of their study, they also conducted a small survey of Ontario EDs and found that only 12% of stretchers and beds have pressure-reduction mattresses. Annually in Ontario, about 240,000 elderly patients are admitted to EDs; the researchers’ model suggested that providing better mattresses for these patients would prevent 1,005 pressure ulcers and save $7.2 million in health care costs.

 

"Pressure ulcers are a huge but underappreciated problem across multiple settings in our health care system," said Prof. Murray Krahn, principal investigator on the study who is a Professor in the Department of Medicine and Faculty of Pharmacy at U of T and the Director of THETA. "Though they are not the full solution, pressure-reduction mattresses are an inexpensive and easy way to address the problem, particularly among elderly patients admitted to EDs."

 

In other studies, the researchers have found potential for cost reduction through pressure-redistribution mattresses in operating rooms, long-term care homes and other facilities. Through THETA, they are working toward implementing a province-wide strategy on pressure-reduction mattresses with the Ontario Health Technology Advisory Committee (OHTAC) and the Medical Advisory Secretariat at Health Quality Ontario, an independent agency that monitors and promotes improvements in health care in Ontario.

 

Although OHTAC issued evidence-based recommendations in 2009 on preventing pressure ulcers that included use of better mattresses in EDs, operating rooms and long-term care facilities, Pham said the province and country still lack a cohesive and effective strategy. "We need active policies in Canada to transfer our knowledge into practice," said Pham. "But I expect change will happen, because the burden of pressure ulcers is so high and investing in better mattresses is virtually a one-time change."

 

 

  • This study was conducted by the following researchers: Ba’ Pham (Toronto Health Economics and Technology Assessment Collaborative [THETA], University of Toronto), Laura Teague (Wound Care Program), Dr. James Mahoney (Division of Plastic Surgery, Department of Surgery, U of T) Laurie Goodman (Skin and Wound Care, Credit Valley Hospital), Mike Paulden (THETA), Dr. Jeff Poss (Department of Health Studies and Gerontology, University of Waterloo), Dr. Jianli Li (Decision Support Services, St. Michael’s Hospital), Luciano Ieraci (THETA), Steven Carcone (THETA), Dr. Murray Krahn (THETA).

 

  • Funding for this study was provided in part by Health Quality Ontario and the Ontario Ministry of Health and Long-Term Care through THETA. The THETA Collaborative provides technology assessment support for the Ontario Health Technology Advisory Committee and the Medical Advisory Secretariat at Health Quality Ontario.

 


 

University of Toronto, 17.08.2011 Nursing News (tB).

MEDICAL NEWS

Inadequate sequencing of SARS-CoV-2 variants impedes global response to COVID-19
New meta-analysis finds cannabis may be linked to development of…
New guidance on how to diagnosis and manage osteoporosis in…
Starting the day off with chocolate could have unexpected benefits
Better mental health supports for nurses needed, study finds

SCHMERZ PAINCARE

Versorgung verbessern: Deutsche Gesellschaft für Schmerzmedizin fordert die Einführung des…
Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…
Jedes vierte Kind wünscht bessere Schmerzbehandlung
Lebensqualität von Patienten in der dauerhaften Schmerztherapie mit Opioiden verbessern

DIABETES

Bundestag berät über DMP Adipositas: DDG begrüßt dies als Teil…
Mit der Smartwatch Insulinbildung steuern
Verbände fordern bessere Ausbildung und Honorierung von Pflegekräften für Menschen…
Minimalinvasive Geräte warnen ungenügend vor Unterzuckerung
Typ-1-Diabetes und Hashimoto-Thyreoiditis treten häufig gemeinsam auf

ERNÄHRUNG

Wie eine Diät die Darmflora beeinflusst: Krankenhauskeim spielt wichtige Rolle…
DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?
Regelmässiger Koffeinkonsum verändert Hirnstrukturen
Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren

ONKOLOGIE

Anti-Myelom-Therapie mit zusätzlich Daratumumab noch effektiver
Positive Ergebnisse beim fortgeschrittenen Prostatakarzinom: Phase-III-Studie zur Radioligandentherapie mit 177Lu-PSMA-617
Lymphom-News vom EHA2021 Virtual. Alle Berichte sind nun online verfügbar!
Deutsch-dänisches Interreg-Projekt: Grenzübergreifende Fortbildungskurse in der onkologischen Pflege
Sotorasib: Neues Medikament macht Lungenkrebs-Patienten Hoffnung

MULTIPLE SKLEROSE

NMOSD-Erkrankungen: Zulassung von Satralizumab zur Behandlung von Jugendlichen und Erwachsenen
Verzögerte Verfügbarkeit von Ofatumumab (Kesimpta®)
Neuer Biomarker bei Multipler Sklerose ermöglicht frühe Risikoeinschätzung und gezielte…
Multiple Sklerose beginnt oft lange vor der Diagnose
Goldstandard für Versorgung bei Multipler Sklerose

PARKINSON

Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…
Gemeinsam gegen Parkinson: bessere Therapie durch multidisziplinäre Versorgung